Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3683169016 | Product containing clemastine and phenylpropanolamine in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3683170015 | Product containing clemastine and phenylpropanolamine in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3683171016 | Clemastine and phenylpropanolamine in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3709239010 | Clemastine- and phenylpropanolamine-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3709240012 | Product containing clemastine and phenylpropanolamine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5510101000241118 | produit contenant de la clémastine et de la phénylpropanolamine sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clemastine- and phenylpropanolamine-containing product in oral dose form | Is a | Product containing clemastine and phenylpropanolamine (medicinal product) | true | Inferred relationship | Some | ||
| Clemastine- and phenylpropanolamine-containing product in oral dose form | Has active ingredient | Phenylpropanolamine (substance) | true | Inferred relationship | Some | 2 | |
| Clemastine- and phenylpropanolamine-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Clemastine- and phenylpropanolamine-containing product in oral dose form | Is a | Product containing clemastine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Clemastine- and phenylpropanolamine-containing product in oral dose form | Has active ingredient | Clemastine (substance) | true | Inferred relationship | Some | 1 | |
| Clemastine- and phenylpropanolamine-containing product in oral dose form | Is a | Phenylpropanolamine-containing product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Clemastine- and phenylpropanolamine-containing product in oral dose form | Inferred relationship | Some | |
| Clemastine+phenylpropanolamine 0.5/25mg tablet | Is a | False | Clemastine- and phenylpropanolamine-containing product in oral dose form | Inferred relationship | Some | |
| Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form) | Is a | True | Clemastine- and phenylpropanolamine-containing product in oral dose form | Inferred relationship | Some | |
| Clemastine and phenylpropanolamine only product in oral dose form | Is a | True | Clemastine- and phenylpropanolamine-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR